Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-24T20:21:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error screen.
    Difference
    0.3%
    Check dated 2026-10-17T21:51:39.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updates from v3.7.0 to v3.7.1; the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:47.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study record page for NCT02383927 now displays a 403 Forbidden error page instead of the usual study details, replacing content with a generic error screen. This indicates an access restriction or server-side issue preventing viewing the study record on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-19T20:58:34.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a software release update rather than a modification to study data.
    Difference
    0.0%
    Check dated 2026-08-29T21:52:15.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a software release rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-08-08T17:43:15.000Z thumbnail image

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.